Cell protective functions of secretory clusterin (SCLU)

Advances in Cancer Research

Volumn 104, Issue 1, 2009, Pages 115-138

  Klock, Gerd ^a   Baiersdörfer, Markus ^a   Koch Brandt, Claudia ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

ANIMAL; APOPTOSIS; HUMAN; METABOLISM; NECROSIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CLUSTERIN; HUMANS; NECROSIS; SIGNAL TRANSDUCTION;

EID: 73949147037     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(09)04007-X     Document Type: Review

References (146)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3, 745-756.
2. Ahn, H. J., Bae, J., Lee, S., Ko, J. E., Yoon, S., Kim, S. J., and Sakuragi, N. (2008). Differential expression of clusterin according to histological type of endometrial carcinoma. Gynecol. Oncol. 110, 222-229.
3. Ammar, H., and Closset, J. L. (2008). Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283, 12851-12861.
4. Bach, U. C., Baiersdorfer, M., Klock, G., Cattaruzza, M., Post, A., and Koch-Brandt, C. (2001). Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein J (clusterin) gene expression in vital fibroblasts. Exp. Cell Res. 265, 11-20.
5. Baiersdörfer, M., Schwarz, M., Bergner, O., Heit, A., Wagner, H., Kirschning, C. J., and Koch-Brandt, C. Expression of apolipoprotein J in vascular smooth muscle cells is induced by RNA released from necrotic cells via Toll-like receptor 3. (manuscript submitted for publication).
6. Bailey, R. W., Aronow, B., Harmony, J. A., and Griswold, M. D. (2002). Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol. Reprod. 66, 1042-1053.
7. Bajari, T. M., Strasser, V., Nimpf, J., and Schneider, W. J. (2003). A model for modulation of leptin activity by association with clusterin. FASEB J. 17, 1505-1507.
8. Bandyk, M. G., Sawczuk, I. S., Olsson, C. A., Katz, A. E., and Buttyan, R. (1990). Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury. J. Urol. 143, 407-413.
9. Bartl, M. M., Luckenbach, T., Bergner, O., Ullrich, O., and Koch-Brandt, C. (2001). Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp. Cell Res. 271, 130-141.
10. Baumann, I., Kolowos, W., Voll, R. E., Manger, B., Gaipl, U., Neuhuber, W. L., Kirchner, T., Kalden, J. R., and Herrmann, M. (2002). Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46, 191-201.
11. Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., and Zlokovic, B. V. (2007). Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27, 909-918.
12. Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., and Lusis, A. J. (1995). Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91, 2488-2496.
13. Bhakdi, S., Dorweiler, B., Kirchmann, R., Torzewski, J., Weise, E., Tranum-Jensen, J., Walev, I., and Wieland, E. (1995). On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182, 1959-1971.
14. Bhakdi, S., Torzewski, M., Paprotka, K., Schmitt, S., Barsoom, H., Suriyaphol, P., Han, S. R., Lackner, K. J., and Husmann, M. (2004). Possible protective role for C-reactive protein in atherogenesis: Complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 109, 1870-1876.
15. Boucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G., and Herz, J. (2002). Plateletderived growth factormediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J. Biol. Chem. 277, 15507-15513.
16. Brändström, A., Westin, P., Bergh, A., Cajander, S., and Damber, J. E. (1994). Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Cancer Res. 54, 3594-3601.
17. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
18. Bursch, W., Gleeson, T., Kleine, L., and Tenniswood, M. (1995). Expression of clusterin (testosterone-repressed prostate message-2) mRNA during growth and regeneration of rat liver. Arch. Toxicol. 69, 253-258.
19. Buttyan, R., Olsson, C. A., Pintar, J., Chang, C., Bandyk, M., Ng, P. Y., and Sawczuk, I. S. (1989). Induction of the TRPM-2 gene in cells undergoing programmed death. Mol. Cell. Biol. 9, 3473-3481.
20. Caccamo, A. E., Scaltriti, M., Caporali, A., D'Arca, D., Scorcioni, F., Candiano, G., Mangiola, M., and Bettuzzi, S. (2003). Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann. N. Y. Acad. Sci. 1010, 514-519.
21. Calero, M., Tokuda, T., Rostagno, A., Kumar, A., Zlokovic, B., Frangione, B., and Ghiso, J. (1999). Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem. J. 344(Pt. 2), 375-383.
22. Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., and Ghiso, J. (2000). Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 50, 305-315.
23. Chavez-Galan, L., Arenas-Del Angel, M. C., Zenteno, E., Chavez, R., and Lascurain, R. (2009). Cell death mechanisms induced by cytotoxic lymphocytes. Cell. Mol. Immunol 6, 15-25.
24. Chen, H., Tritton, T. R., Kenny, N., Absher, M., and Chiu, J. F. (1996). Tamoxifen induces TGFbeta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J. Cell. Biochem. 61, 9-17.
25. Chen, T., Turner, J., McCarthy, S., Scaltriti, M., Bettuzzi, S., and Yeatman, T. J. (2004). Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. Cancer Res. 64, 7412-7419.
26. Chen, S., Bu, G., Takei, Y., Sakamoto, K., Ikematsu, S., Muramatsu, T., and Kadomatsu, K. (2007). Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J Cell Sci. 120, 4009-4015.
27. Chou, T. Y., Chen, W. C., Lee, A. C., Hung, S. M., Shih, N. Y., and Chen, M. Y. (2009). Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cell Signal. 21, 704-711.
28. Chun, J. T., Wang, L., Pasinetti, G. M., Finch, C. E., and Zlokovic, B. V. (1999). Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp. Neurol. 157, 194-201.
29. D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479.
30. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., and Zlokovic, B. V. (2008). apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 118, 4002-4013.
31. deGoma, E. M., deGoma, R. L., and Rader, D. J. (2008). Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol. 51, 2199-2211.
32. DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A., Aronow, B. J., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2004). ApoE and clusterin cooperatively suppress Abeta levels and deposition: Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41, 193-202.
33. de Silva, H. V., Stuart, W. D., Duvic, C. R., Wetterau, J. R., Ray, M. J., Ferguson, D. G., Albers, H.W., Smith, W. R., and Harmony, J. A. (1990). A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J. Biol. Chem. 265, 13240-13247.
34. Devauchelle, V., Essabbani, A., De Pinieux, G., Germain, S., Tourneur, L., Mistou, S., Margottin-Goguet, F., Anract, P., Migaud, H., Le Nen, D., Lequerre, T., Saraux, A., et al. (2006). Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J. Immunol. 177, 6471-6479.
35. Erwig, L. P., and Henson, P. M. (2008). Clearance of apoptotic cells by phagocytes. Cell Death Differ. 15, 243-250.
36. Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., and Henson, P. M. (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90.
37. Farquhar, M. G., Saito, A., Kerjaschki, D., and Orlando, R. A. (1995). The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J. Am. Soc. Nephrol. 6, 35-47.
38. French, L. E., Wohlwend, A., Sappino, A. P., Tschopp, J., and Schifferli, J. A. (1994). Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest. 93, 877-884.
39. Frey, B., Munoz, L. E., Pausch, F., Sieber, R., Franz, S., Brachvogel, B., Poschl, E., Schneider, H., Rodel, F., Sauer, R., Fietkau, R., Herrmann, M., et al. (2008). The immune reaction against allogeneic necrotic cells is reduced in AnnexinA5 knock out mice whose macrophages display an anti-inflammatory phenotype. J. Cell. Mol. Med. 20, 20.
40. Fries, D. M., Lightfoot, R., Koval, M., and Ischiropoulos, H. (2005). Autologous apoptotic cell engulfment stimulates chemokine secretion by vascular smooth muscle cells. Am. J. Pathol. 167, 345-353.
41. Funk, C. D., and FitzGerald, G. A. (2007). COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470-479.
42. Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., and Frangione, B. (1993). The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293(Pt. 1), 27-30.
43. Gordon, D. J., and Rifkind, B. M. (1989). High-density lipoprotein-The clinical implications of recent studies. N. Engl. J. Med. 321, 1311-1316.
44. Greijer, A. E., and van der Wall, E. (2004). The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57, 1009-1014.
45. Hammad, S. M., Ranganathan, S., Loukinova, E., Twal, W. O., and Argraves, W. S. (1997). Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J. Biol. Chem. 272, 18644-18649.
46. Hart, S. P., Smith, J. R., and Dransfield, I. (2004). Phagocytosis of opsonized apoptotic cells: Roles for 'old-fashioned' receptors for antibody and complement.Clin.Exp. Immunol. 135, 181-185.
47. Henson, P. M., and Hume, D. A. (2006). Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27, 244-250.
48. Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., and Kalden, J. R. (1998). Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41, 1241-1250.
49. Hiesberger, T., Trommsdorff, M., Howell, B.W., Goffinet, A., Mumby, M. C., Cooper, J. A., and Herz, J. (1999). Direct binding of Reelin toVLDLreceptor andApoEreceptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489.
50. Holt, S. K., Karyadi, D. M., Kwon, E. M., Stanford, J. L., Nelson, P. S., and Ostrander, E. A. (2008). Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin. Cancer Res. 14, 3823-3831.
51. Ishikawa, Y., Akasaka, Y., Ishii, T., Komiyama, K., Masuda, S., Asuwa, N., Choi-Miura, N. H., and Tomita, M. (1998). Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler. Thromb. Vasc. Biol. 18, 665-672.
52. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. J., Hama, E., Sekine-Aizawa, Y., and Saido, T. C. (2000). Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
53. Jeannin, P., Jaillon, S., and Delneste, Y. (2008). Pattern recognition receptors in the immune response against dying cells. Curr. Opin. Immunol. 20, 530-537.
54. Jenne, D. E., Lowin, B., Peitsch, M. C., Bottcher, A., Schmitz, G., and Tschopp, J. (1991). Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J. Biol. Chem. 266, 11030-11036.
55. Jo, H., Jia, Y., Subramanian, K. K., Hattori, H., and Luo, H. R. (2008). Cancer cell-derived clusterin modulates the phosphatidylinositol 3¢-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation. Mol. Cell. Biol. 28, 4285-4299.
56. Józefowski, S., Arredouani, M., Sulahian, T., and Kobzik, L. (2005). Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J. Immunol. 175, 8032-8041.
57. Kadomatsu, K., Anzano, M. A., Slayter, M. V., Winokur, T. S., Smith, J. M., and Sporn, M. B. (1993). Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res. 53, 1480-1483.
58. Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., and Koo, E. H. (2000). Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J. Clin. Invest. 106, 1159-1166.
59. Kawamura, A., Baitsch, D., Telgmann, R., Feuerborn, R., Weissen-Plenz, G., Hagedorn, C., Saku, K., Brand-Herrmann, S. M., von Eckardstein, A., Assmann, G., and Nofer, J. R. (2007). Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27, 1610-1617.
60. Kim, J. H., Yu, Y. S., Kim, K.W., and Min, B. H. (2007). The role of clusterin in in vitro ischemia of human retinal endothelial cells. Curr. Eye Res. 32, 693-698.
61. Klock, G., Storch, S., Rickert, J., Gutacker, C., and Koch-Brandt, C. (1998). Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis. J. Cell. Physiol. 177, 593-605.
62. Koch-Brandt, C., and Morgans, C. (1996). Clusterin: A role in cell survival in the face of apoptosis? Prog. Mol. Subcell. Biol 16, 130-149.
63. Kolb, S., Vranckx, R., Huisse, M. G., Michel, J. B., and Meilhac, O. (2007). The phosphatidylserine receptor mediates phagocytosis by vascular smooth muscle cells. J. Pathol. 212, 249-259.
64. Kounnas, M. Z., Loukinova, E. B., Stefansson, S., Harmony, J. A., Brewer, B. H., Strickland, D. K., and Argraves, W. S. (1995). Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070-13075.
65. Kujiraoka, T., Hattori, H., Miwa, Y., Ishihara, M., Ueno, T., Ishii, J., Tsuji, M., Iwasaki, T., Sasaguri, Y., Fujioka, T., Saito, S., Tsushima, M., et al. (2006). Serum apolipoprotein J in health, coronary heart disease and type 2 diabetes mellitus. J. Atheroscler. Thromb. 13, 314-322.
66. Kyprianou, N., English, H. F., Davidson, N. E., and Isaacs, J. T. (1991). Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51, 162-166.
67. LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., and van Eldik, L. J. (2000). Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974-33980.
68. Lakins, J. N., Poon, S., Easterbrook-Smith, S. B., Carver, J. A., Tenniswood, M. P., and Wilson, M. R. (2002). Evidence that clusterin has discrete chaperone and ligand binding sites. Biochemistry 41, 282-291.
69. Lawrence, T., and Gilroy, D. W. (2007). Chronic inflammation: A failure of resolution? Int. J. Exp. Pathol. 88, 85-94.
70. Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J., and Boothman, D. A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590-11600.
71. Lillis, A. P., Greenlee, M. C., Mikhailenko, I., Pizzo, S. V., Tenner, A. J., Strickland, D. K., and Bohlson, S. S. (2008). Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. J. Immunol. 181, 364-373.
72. Lu, J. H., Teh, B. K., Wang, L., Wang, Y. N., Tan, Y. S., Lai, M. C., and Reid, K. B. (2008). The classical and regulatory functions of C1q in immunity and autoimmunity. Cell. Mol. Immunol. 5, 9-21.
73. Marzolo, M. P., Yuseff, M. I., Retamal, C., Donoso, M., Ezquer, F., Farfan, P., Li, Y., and Bu, G. (2003). Differential distribution of low-density lipoprotein-receptor-related protein (LRP) and megalin in polarized epithelial cells is determined by their cytoplasmic domains. Traffic 4, 273-288.
74. Matsuda, A., Itoh, Y., Koshikawa, N., Akizawa, T., Yana, I., and Seiki, M. (2003). Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. J. Biol. Chem. 278, 36350-36357.
75. May, P., Herz, J., and Bock, H. H. (2005). Molecular mechanisms of lipoprotein receptor signalling. Cell. Mol. Life Sci. 62, 2325-2338.
76. McLoughlin, D. M., and Miller, C. C. (2008). The FE65 proteins and Alzheimer's disease. J. Neurosci. Res. 86, 744-754.
77. McLaughlin, L., Zhu, G., Mistry, M., Ley-Ebert, C., Stuart, W. D., Florio, C. J., Groen, P. A., Witt, S. A., Kimball, T. R., Witte, D. P., Harmony, J. A., and Aronow, B. J. (2000). Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106, 1105-1113.
78. Millis, A. J., Luciani, M., McCue, H. M., Rosenberg, M. E., and Moulson, C. L. (2001). Clusterin regulates vascular smooth muscle cell nodule formation and migration. J. Cell. Physiol. 186, 210-219.
79. Mitchell, J. E., Cvetanovic, M., Tibrewal, N., Patel, V., Colamonici, O. R., Li, M. O., Flavell, R. A., Levine, J. S., Birge, R. B., and Ucker, D. S. (2006). The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. J. Biol. Chem. 281, 5718-5725.
80. Miyake, H., Nelson, C., Rennie, P. S., and Gleave, M. E. (2000). Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res. 60, 2547-2554.
81. Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. (2007). Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435-439.
82. Moretti, R. M., Marelli, M. M., Mai, S., Cariboni, A., Scaltriti, M., Bettuzzi, S., and Limonta, P. (2007). Clusterin isoforms differentially affect growth and motility of prostate cells: Possible implications in prostate tumorigenesis. Cancer Res. 67, 10325-10333.
83. Moulson, C. L., and Millis, A. J. (1999). Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro. J. Cell. Physiol. 180, 355-364.
84. Munoz, L. E., van Bavel, C., Franz, S., Berden, J., Herrmann, M., and van der Vlag, J. (2008). Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17, 371-375.
85. Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., Laks, H., and Fogelman, A. M. (1991). Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88, 2039-2046.
86. Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L.W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., and La Du, B. N. (1997). Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J. Clin. Invest. 99, 2005-2019.
87. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J., Wagner, A. C., Hama, S., Hough, G., Bachini, E., Garber, D. W., Mishra, V. K., Palgunachari, M. N., and Fogelman, A. M. (2005). An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 25, 1932-1937.
88. Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J., Buga, G. M., and Fogelman, A. M. (2007). Peptide mimetics of apolipoproteins improve HDL function. J. Clin. Lipidol. 1, 142-147.
89. Newkirk, M. M., Apostolakos, P., Neville, C., and Fortin, P. R. (1999). Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein. J. Rheumatol. 26, 597-603.
90. Newton, C. S., Loukinova, E., Mikhailenko, I., Ranganathan, S., Gao, Y., Haudenschild, C., and Strickland, D. K. (2005). Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J. Biol. Chem. 280, 27872-27878.
91. Nuutinen, T., Huuskonen, J., Suuronen, T., Ojala, J., Miettinen, R., and Salminen, A. (2007). Amyloid-beta 1-42 induced endocytosis and clusterin/apoJ protein accumulation in cultured human astrocytes. Neurochem. Int. 50, 540-547.
92. Owens, G. K., Kumar, M. S., and Wamhoff, B. R. (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801.
93. Parczyk, K., Pilarsky, C., Rachel, U., and Koch-Brandt, C. (1994). Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J. Cancer Res. Clin. Oncol. 120, 186-188.
94. Paresce, D. M., Ghosh, R. N., and Maxfield, F. R. (1996). Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565.
95. Park, D., Tosello-Trampont, A. C., Elliott, M. R., Lu, M., Haney, L. B., Ma, Z., Klibanov, A. L., Mandell, J.W., and Ravichandran, K. S. (2007). BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 450, 430-434.
96. Patel, V. A., Longacre, A., Hsiao, K., Fan, H., Meng, F., Mitchell, J. E., Rauch, J., Ucker, D. S., and Levine, J. S. (2006). Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearancemodel of autoimmunity. J. Biol. Chem. 281, 4663-4670.
97. Pereira, I. A., and Borba, E. F. (2008). The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med. Wkly 138, 534-539.
98. Platt, N., da Silva, R. P., and Gordon, S. (1998). Recognizing death: The phagocytosis of apoptotic cells. Trends Cell Biol. 8, 365-372.
99. Poulios, E., Trougakos, I. P., and Gonos, E. S. (2006). Comparative effects of hypoxia on normal and immortalized human diploid fibroblasts. Anticancer Res. 26, 2165-2168.
100. Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., and Selkoe, D. J. (1998). Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273, 32730-32738.
101. Ranney, M. K., Ahmed, I. S., Potts, K. R., and Craven, R. J. (2007). Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochim. Biophys. Acta 1772, 1103-1111.
102. Redondo, M., Villar, E., Torres-Munoz, J., Tellez, T., Morell, M., and Petito, C. K. (2000). Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. 157, 393-399.
103. Santilli, G., Aronow, B. J., and Sala, A. (2003). Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J. Biol. Chem. 278, 38214-38219.
104. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000). Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-434.
105. Savill, J., and Gregory, C. (2007). Apoptotic PS to phagocyte TIM-4: Eat me. Immunity 27, 830-832.
106. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002). A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975.
107. Schillinger, M., and Minar, E. (2005). Restenosis after percutaneous angioplasty: The role of vascular inflammation. Vasc. Health Risk Manag. 1, 73-78.
108. Schober, A., and Zernecke, A. (2007). Chemokines in vascular remodeling. Thromb. Haemost. 97, 730-737.
109. Schrijvers, D. M., De Meyer, G. R., Kockx, M. M., Herman, A. G., and Martinet, W. (2005). Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1256-1261.
110. Schwarz, M., Spath, L., Lux, C. A., Paprotka, K., Torzewski, M., Dersch, K., Koch-Brandt, C., Husmann, M., and Bhakdi, S. (2008). Potential protective role of apoprotein J (clusterin) in atherogenesis: Binding to enzymatically modified low-density lipoprotein reduces fatty acidmediated cytotoxicity. Thromb. Haemost. 100, 110-118.
111. Selkoe, D. J. (2001). Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81, 741-766.
112. Sensibar, J. A., Sutkowski, D. M., Raffo, A., Buttyan, R., Griswold, M. D., Sylvester, S. R., Kozlowski, J. M., and Lee, C. (1995). Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res. 55, 2431-2437.
113. Shannan, B., Seifert, M., Leskov, K., Willis, J., Boothman, D., Tilgen, W., and Reichrath, J. (2006). Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13, 12-19.
114. Shayo, M., McLay, R. N., Kastin, A. J., and Banks, W. A. (1997). The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations. Life Sci. 60, PL115-PL118.
115. Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., and Zlokovic, B. V. (2000). Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood- brain barrier. J. Clin. Invest. 106, 1489-1499.
116. Shim, Y. J., Shin, Y. J., Jeong, S. Y., Kang, S. W., Kim, B. M., Park, I. S., and Min, B. H. (2009). Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation. Neuroreport 20, 435-439.
117. Sintich, S. M., Steinberg, J., Kozlowski, J. M., Lee, C., Pruden, S., Sayeed, S., and Sensibar, J. A. (1999). Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin). Prostate 39, 87-93.
118. Strickland, D. K., and Ranganathan, S. (2003). Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J. Thromb. Haemost. 1, 1663-1670.
119. Strickland, D. K., Kounnas, M. Z., and Argraves, W. S. (1995). LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9, 890-898.
120. Tan, P. H., Sagoo, P., Chan, C., Yates, J. B., Campbell, J., Beutelspacher, S. C., Foxwell, B. M., Lombardi, G., and George, A. J. (2005). Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. 174, 7633-7644.
121. Terrand, J., Bruban, V., Zhou, L., Gong, W., El Asmar, Z., May, P., Zurhove, K., Haffner, P., Philippe, C., Woldt, E., Matz, R. L., Gracia, C., et al. (2009). LRP1 controls intracellular cholesterol storage and fatty acid synthesis through modulation of Wnt signaling. J. Biol. Chem. 284, 381-388.
122. Torzewski, M., Suriyaphol, P., Paprotka, K., Spath, L., Ochsenhirt, V., Schmitt, A., Han, S. R., Husmann, M., Gerl, V. B., Bhakdi, S., and Lackner, K. J. (2004). Enzymatic modification of low-density lipoprotein in the arterial wall: A new role for plasmin and matrix metalloproteinases in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 2130-2136.
123. Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., and Herz, J. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.
124. Trougakos, I. P., and Gonos, E. S. (2002). Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell. Biol. 34, 1430-1448.
125. Trougakos, I. P., Lourda, M., Antonelou, M. H., Kletsas, D., Gorgoulis, V. G., Papassideri, I. S., Zou, Y., Margaritis, L. H., Boothman, D. A., and Gonos, E. S. (2009). Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin. Cancer Res. 15, 48-59.
126. Tschopp, J., and French, L. E. (1994). Clusterin: Modulation of complement function. Clin. Exp. Immunol. 97, 11-14.
127. Vandivier, R. W., Ogden, C. A., Fadok, V. A., Hoffmann, P. R., Brown, K. K., Botto, M., Walport, M. J., Fisher, J. H., Henson, P. M., and Greene, K. E. (2002a). Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: Calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169, 3978-3986.
128. Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., and Henson, P. M. (2002b). Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest. 109, 661-670.
129. Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., and Navab, M. (1995). Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96, 2758-2767.
130. Viorritto, I. C., Nikolov, N. P., and Siegel, R. M. (2007). Autoimmunity versus tolerance: Can dying cells tip the balance? Clin. Immunol. 122, 125-134.
131. von Vietinghoff, S., and Ley, K. (2008). Homeostatic regulation of blood neutrophil counts. J. Immunol. 181, 5183-5188.
132. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
133. Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., and Navab, M. (1995). Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96, 2882-2891.
134. Wellmann, A., Thieblemont, C., Pittaluga, S., Sakai, A., Jaffe, E. S., Siebert, P., and Raffeld, M. (2000). Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood 96, 398-404.
135. Wilson, M. R., and Easterbrook-Smith, S. B. (2000). Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25, 95-98.
136. Witte, D. P., Aronow, B. J., Stauderman, M. L., Stuart, W. D., Clay, M. A., Gruppo, R. A., Jenkins, S. H., and Harmony, J. A. (1993). Platelet activation releases megakaryocytesynthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am. J. Pathol. 143, 763-773.
137. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., and Husemann, J. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457.
138. Yerbury, J. J., and Wilson, M. R. (2009). Extracellular chaperones modulate the effects of Alzheimer's patient cerebrospinal fluid on Abeta(1-42) toxicity and uptake. Cell Stress Chaperones [Epub ahead of print], PMID: 19472074.
139. Yoshimura, S., Bondeson, J., Brennan, F. M., Foxwell, B. M., and Feldmann, M. (2001). Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur. J. Immunol. 31, 1883-1893.
140. You, K. H., Ji, Y. M., and Kwon, O. Y. (2003). Clusterin overexpression is responsible for the antiapoptosis effect in a mouse neuroblastoma cell line, B103. Z. Naturforsch. [C] 58, 148-151.
141. Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R., andWang, C. Y. (2005). Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7, 909-915.
142. Zhou, J., Schmid, T., Schnitzer, S., and Brune, B. (2006). Tumor hypoxia and cancer progression. Cancer Lett. 237, 10-21.
143. Zlokovic, B. V. (2004). Clearing amyloid through the blood-brain barrier. J. Neurochem. 89, 807-811.
144. Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., and Ghiso, J. (1996). Glycoprotein 330/megalin: Probable role in receptormediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93, 4229-4234.
145. Züllig, S., and Hengartner, M. O. (2004). Cell biology. Tickling macrophages, a serious business. Science 304, 1123-1124.
146. Zurhove, K., Nakajima, C., Herz, J., Bock, H. H., and May, P. (2008). Gamma-secretase limits the inflammatory response through the processing of LRP1. Sci. Signal. 1, ra15.